Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
30–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients at screening must be insulin producing Type II diabetics (C peptide positive).
Patients must have a history of mild to moderate hypertension (140-179 systolic blood pressure; 90-1-9 diastolic blood pressure)
Patients must be on a stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments.
Patients must be on stable antidiabetic regimen (drug treated or diet alone).
Patient''s laboratory result for HbA1c must be 6.5 - 8.5 (drug treated) or 6.5 - 7.5 (diet alone).
You may not be if
Patients using beta-blocker therapy.
Clareo Health | Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
